108 related articles for article (PubMed ID: 11907740)
1. GPIIb-IIIa receptor inhibitors: what the interventional radiologist needs to know.
Hofmann LV; Razavi M; Arepally A; Reginelli JP; Resar J; Geschwind JF; Corl F
Cardiovasc Intervent Radiol; 2001; 24(6):361-7. PubMed ID: 11907740
[TBL] [Abstract][Full Text] [Related]
2. Use of glycoprotein IIb/IIIa platelet inhibitors in peripheral vascular interventions.
Ansel GM; George BS; Botti CF; Silver MJ
Rev Cardiovasc Med; 2002; 3 Suppl 1():S35-40. PubMed ID: 12439435
[TBL] [Abstract][Full Text] [Related]
3. Use of GPIIb/IIIa inhibitors in cardiovascular medicine.
Ahrens I; Peter K; Bode C
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283
[TBL] [Abstract][Full Text] [Related]
4. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
Lee DS; Bhatt DL; Moliterno DJ; Peacock WF; Ellis SG; Topol EJ
J Invasive Cardiol; 2004 Feb; 16(2):46-51. PubMed ID: 14760188
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies on glycoprotein IIb/IIIa receptor antagonist].
Rasmussen LH; Husted SE; Clemmensen PM; Gøtzsche CO; Helqvist S; Kristensen SD; Pedersen KE; Rasmussen K; Rasmussen S
Ugeskr Laeger; 2000 Oct; 162(44):5944-7. PubMed ID: 11094564
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
Bolognese L
Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
[TBL] [Abstract][Full Text] [Related]
7. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
Tricoci P; Peterson ED
J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
[TBL] [Abstract][Full Text] [Related]
8. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
Harrington RA
Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?
Maree A; Fitzgerald DJ
Semin Vasc Med; 2003 Nov; 3(4):385-90. PubMed ID: 15199445
[TBL] [Abstract][Full Text] [Related]
10. Use of glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes.
Lepor NE
Rev Cardiovasc Med; 2002; 3 Suppl 1():S3-S12. PubMed ID: 12439431
[TBL] [Abstract][Full Text] [Related]
11. GP IIb/IIIa blockade during peripheral artery interventions.
Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH
Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207
[TBL] [Abstract][Full Text] [Related]
12. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events.
Collet JP; Montalescot G; Agnelli G; Van de Werf F; Gurfinkel EP; López-Sendón J; Laufenberg CV; Klutman M; Gowda N; Gulba D;
Eur Heart J; 2005 Nov; 26(21):2285-93. PubMed ID: 15932908
[TBL] [Abstract][Full Text] [Related]
13. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).
Montalescot G; Van de Werf F; Gulba DC; Avezum A; Brieger D; Kennelly BM; Mazurek T; Spencer F; White K; Gore JM;
Catheter Cardiovasc Interv; 2003 Nov; 60(3):360-7. PubMed ID: 14571488
[TBL] [Abstract][Full Text] [Related]
14. Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
Pieper KS; Tsiatis AA; Davidian M; Hasselblad V; Kleiman NS; Boersma E; Chang WC; Griffin J; Armstrong PW; Califf RM; Harrington RA
Circulation; 2004 Feb; 109(5):641-6. PubMed ID: 14769687
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes.
Shimpi RA
J Invasive Cardiol; 2003 Aug; 15(8):460-5. PubMed ID: 12890880
[No Abstract] [Full Text] [Related]
16. [Glycoprotein IIB/IIIA receptor blockers as treatment of acute coronary syndromes and interventional cardiology].
Abramovitch N; Halon DA; Flugelman Y; Lewis BS
Harefuah; 1998 Jul; 135(1-2):41-7. PubMed ID: 10909532
[No Abstract] [Full Text] [Related]
17. [Acute coronary syndrome: peri-interventional antithrombotic therapy].
Wichter T
Hamostaseologie; 2006 May; 26(2):138-46. PubMed ID: 16676057
[TBL] [Abstract][Full Text] [Related]
18. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
19. Acute coronary syndrome: new advances and nursing strategies.
Palatnik AM
Dimens Crit Care Nurs; 2000; 19(5):22-6. PubMed ID: 11998062
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein IIb-IIIa inhibitors in unstable coronary syndromes and percutaneous interventions--a conservative approach.
De Caterina R; Di Gioacchino L
Rev Port Cardiol; 2003; 22(7-8):995-1002. PubMed ID: 14587167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
